In the future, large scale patient samples are needed to confirm the biomarker role of this MALAT1/miR-144-3p axis and also more mouse models are needed to be employed to verify its potential as therapeutic target to treat MI. This evidence concerns the gene MALAT1 and myocardial infarction.